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Available online xxxxObjective: Physical activity (PA) improves health outcomes in people with schizophrenia. It is unclear howmuch
PA people with schizophrenia undertake andwhat inﬂuences PA participation.We conducted ameta-analysis to
investigate PA levels and predictors in people with schizophrenia.
Method:Major databases were searched from inception till 02/2016 for articles measuring PA (self-report ques-
tionnaire (SRQ) or objective measure (e.g. accelerometer)) in people with schizophrenia, including ﬁrst episode
psychosis (FEP). A random effects meta-analysis and meta-regression analysis were conducted.
Results: 35 studies representing 3453 individualswith schizophrenia (40.0 years; 64.0%male)were included. En-
gagement in light PA was 80.44 min (95% CI 68.32–92.52, n = 2658), 47.1 min moderate-vigorous PA (95% CI
31.5–62.8, n = 559) and 1.05 min (95% CI 0.48–1.62, n= 2533) vigorous PA per day. People with schizophrenia
engaged in signiﬁcantly less moderate (hedges g =−0.45, 95% CI−0.79 to−0.1, p = 0.01) and vigorous PA
(g =−0.4, 95% CI−0.60 to −0.18) versus controls. Higher light to moderate, but lower vigorous PA levels
were observed in outpatients and in studies utilizing objective measures versus SRQ. 56.6% (95% CI 45.8–66.8,
studies = 12) met the recommended 150 min of moderate physical activity per week. Depressive symptoms
and older age were associated with less vigorous PA in meta-regression analyses.
Conclusions:Our data conﬁrm that people with schizophrenia engage in signiﬁcantly less moderate and vigorous
PA versus controls. Interventions aiming to increase PA, regardless of intensity are indicated for people with
schizophrenia, while speciﬁcally increasing moderate-vigorous PA should be a priority given the established
health beneﬁts.
© 2016 Elsevier B.V. All rights reserved.Keywords:
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Schizophrenia1. Introduction
People with schizophrenia experience a premature mortality gap of
between 10 and 20 years from the general population (Walker et al.,
2015). There is an abundance of literature demonstrating that people
with schizophrenia experience high levels of metabolic syndromet, South London and Maudsley
dom.
much physical activity do pe
. Res. (2016), http://dx.doi.or(Mitchell et al., 2013; Vancampfort et al., 2015d), type two diabetes
(Stubbs et al., 2015b) and cardiovascular disease (Gardner-Sood et al.,
2015),which collectively account for over 70% of the prematuremortal-
ity in this group (Lawrence et al., 2013).
There is promising evidence that physical activity (PA) interventions
can improve cardio-metabolic outcomes and improve mental health
symptoms in people with schizophrenia (Firth et al., 2015;
Rosenbaum et al., 2014). Even in the absence of a change in weight
status, PA can result in improvements in cardiorespiratory ﬁtness
(Vancampfort et al., 2015c), which is a better predictor of mortalityoplewith schizophrenia engage in? A systematic review, comparative
g/10.1016/j.schres.2016.05.017
2 B. Stubbs et al. / Schizophrenia Research xxx (2016) xxx–xxxthan BMI in the general population (Barry et al., 2014). There is also
emerging evidence that PA can improve cognition in people with
schizophrenia (Kimhy et al., 2016). However, people with psychotic
disorders are highly sedentary (Stubbs et al., 2015a, 2016) and expe-
rience a range of barriers to PA such as negative symptoms, pain and
the side-effects of medication (Soundy et al., 2014a; Vancampfort et
al., 2011, 2012). Consequently, it might be hypothesized that many
people with schizophrenia do not meet recommended PA guidelines
such as accruing 150 min of moderate-vigorous PA per week
(Vancampfort, 2012). It remains unclear exactly how much PA peo-
ple with schizophrenia engage in, and at what intensity (i.e. light,
moderate and vigorous). Moreover, the moderators of PA participa-
tion are not fully elucidated.
Given that physical activity is a modiﬁable risk factor for cardiovas-
cular disease and can simultaneously improve symptoms, understand-
ing physical activity levels and predictors among people with
schizophrenia is of high clinical signiﬁcance. To our knowledge, only
one preliminary review has considered PA levels (Soundy et al., 2013)
in people with schizophrenia. The authors (Soundy et al., 2013) focused
only on outpatients and found that across three studies, people with
schizophrenia engage in less light, moderate and vigorous physical ac-
tivities compared to controls (p b 0.01). Since this review was pub-
lished, there has been a rapid increase in the number of published
papers on PA and schizophrenia, however a number of pertinent ques-
tions remain unanswered. For instance, it remains unclear how much
time people with schizophrenia engage in each category of PA (light,
moderate and vigorous) andwhich factors (e.g. negative symptoms, de-
pressive symptoms, cognitive symptoms, mean age) inﬂuence PA. Un-
derstanding this has important implications for the successful delivery
of interventions aiming to increase PA participation in practice. More-
over, some studies have utilized self-report questionnaires (SRQ) to
measure PA and others have used objective measures such as acceler-
ometers (the gold standard; (Soundy et al., 2013, 2014b)). There are
concerns that SRQ overestimate PA and research is required to investi-
gate if SRQ report different levels of physical activity compared to objec-
tive measurements (Soundy et al., 2014b). Finally, it remains unclear if
people with schizophrenia are less physically active than controls and
exactly what this difference (if any) is.
Given the aforementioned, we set out to conduct a systematic re-
view with the following aims 1) establish the mean time of light, mod-
erate and vigorous PA in people with schizophrenia per day. 2)
Investigate differences in PA between SRQ and objective measures. 3)
Investigate moderators of each category of PA in meta-regression anal-
yses. 4) Investigate differences in PA in people with schizophrenia ver-
sus controls.
2. Method
This systematic review adhered to the MOOSE guidelines (Stroup et
al., 2000) and PRISMA statement (Moher et al., 2009).
2.1. Inclusion criteria
We included studies that: (a) included adult participants with a
diagnosis of schizophrenia spectrum disorder (including ﬁrst epi-
sode psychosis) according to established criteria (e.g., DSM-IV,
(American Psychiatric Association, 2000) or ICD-10, (World Health
Organisation, 1993)). Studies with mixed samples of mental ill-
nesses (e.g. psychotic disorders) were only eligible if N80% of the
sample had schizophrenia and/ or reported the data speciﬁcally for
those with schizophrenia. (b) Reported the amount of time of PA
participation including light, moderate, moderate-vigorous, vigor-
ous and total PA per day with either a SRQ (e.g. IPAQ (Craig et al.,
2003)) or objective measure (e.g. accelerometer). Physical activity
was deﬁned as any intervention that uses bodily movement pro-
duced by skeletal muscles and which requires energy expenditurePlease cite this article as: Stubbs, B., et al., Howmuch physical activity do pe
meta-analysis and meta-regress..., Schizophr. Res. (2016), http://dx.doi.or(Caspersen et al., 1985). Studies measuring exercise only, deﬁned
as planned, structured, repetitive and purposive activity seeking to
improve or maintain physical ﬁtness or health was an objective,
were not included. We also included articles that reported the pro-
portion of people with schizophrenia meeting the 150 min per
week of moderate-vigorous PA (c) and were interventional (RCTs,
CCTs) and observational (prospective or cross-sectional) studies
conducted in any setting (inpatients or outpatients). (d) They were
published in an international peer-reviewed journal or a published
dissertation in English language.
2.2. Information sources and searches
Two independent authors searched MEDLINE, PsycINFO, and
EMBASE from inception till 10th February 2016 (schizophrenia or psy-
chosis or schiz*) AND (physical activity or exercise or walking or accel-
erometer or accelero*). In addition, reference lists of all eligible articles
and related systematic reviews were screened to identify potentially el-
igible articles (Soundy et al., 2013).
2.3. Study selection
After removal of duplicates, one reviewer screened titles and ab-
stracts of all potentially eligible articles. A second author conﬁrmed in-
cluded studies and a ﬁnal list of included studies was developed.
2.4. Outcomes
The primary outcomewas themean time (minutes) per day of light,
moderate, and vigorous PA per day that people with schizophrenia en-
gaged in. Physical activity categories are standardized according to the
metabolic equivalents (MET), which illustrates the energy expenditure
categories: light (1.5–3 METs), moderate (3–6 METs), and vigorous
(N6 METs) (Soundy et al., 2013). We also collected data on physical ac-
tivity among healthy controls where possible.
2.5. Data extraction
Two authors (JF, DV) extracted data using a predetermined data ex-
traction form. The data extracted included ﬁrst author, country, setting,
population, type of the study (prospective, controlled or randomized
controlled trial), number of studies and participants included in the ar-
ticle (including mean age, % female, total, negative and positive symp-
toms and depressive symptoms), type and deﬁnition of physical
activity (objective or self-report, reference period), and results.
2.6. Meta-analysis
Due to the anticipated heterogeneity across studies, we conducted a
random effects meta-analysis with Comprehensive Meta-analysis soft-
ware (CMA, Version 3). Themeta-analysis was conducted in the follow-
ing sequence. First, we calculated the mean amount of time spent in
low, moderate, moderate-vigorous and vigorous PA per day (minutes
per day) among people with schizophrenia together with the 95% con-
ﬁdence intervals (CI). Second, we calculated the subgroup differences in
each PA category according to themeasurement (self-report versus ob-
jective measurement), diagnosis (FEP, schizophrenia spectrum and
mixed psychotic disorder). Third, we investigated potential moderators
of PA participation in people with psychosis withMeta regression anal-
yses. The potential moderators of interest were mean age, % of males,
sedentary behavior measurement (objective versus self-report), illness
duration, BMI, depressive symptomsand psychiatric symptoms, deﬁned
as the symptoms of psychotic disease severitymeasured with a validat-
ed scale including total negative and positive symptoms. Fourth, we
conducted a comparative meta-analysis investigating differences in
each PA category among people with schizophrenia and healthyoplewith schizophrenia engage in? A systematic review, comparative
g/10.1016/j.schres.2016.05.017
3B. Stubbs et al. / Schizophrenia Research xxx (2016) xxx–xxxcontrols calculating hedges g and the 95% CI as the effect size. In addi-
tion, we calculated the mean difference in minutes per day together
with the 95% CI. Finally, we calculated the proportion of people with
schizophrenia meeting the recommended PA guidelines together with
95% CI. Heterogeneity was assessed with the I2 statistics for each analy-
sis (Higgins et al., 2003). Publication bias was assessed and adjusted for
with a trim and ﬁll adjusted analysis (Duval and Tweedie, 2000) to re-
move the most extreme small studies from the positive side of the fun-
nel plot, and recalculated the effect size at each iteration, until the
funnel plot was symmetric about the (new) effect size.
3. Results
3.1. Study selection
The initial electronic database searches identiﬁed 2745 articles (ex-
cluding duplicates) which were considered at the title and abstract
level. 234 full texts were reviewed and 199were excludedwith reasons
(see Fig. 1), with 35 unique studies meeting the eligibility criteria
(Arbour-Nicitopoulos et al., 2014; Arbour-Nicitopoulos et al., 2010;
Attux et al., 2013; Baker et al., 2014; Beebe et al., 2011; Bredin et al.,
2013; Brunero and Lamont, 2010; Curtis et al., 2015; Faulkner et al.,
2006; Firth et al., 2016; Gardner-Sood et al., 2015; Gomes et al., 2014,
2015; Gorczynski et al., 2014; Janney, 2012; Janney et al., 2015;
Keller-Varady et al., 2015; Kimhy et al., 2014; Leutwyler et al., 2013,
2015; Lindamer et al., 2008; Lovell et al., 2014; Masa-Font et al., 2015;
McCreadie, 2003; McKibbin et al., 2006; McLeod et al., 2009; MorganFig. 1. Prisma ﬂo
Please cite this article as: Stubbs, B., et al., Howmuch physical activity do pe
meta-analysis and meta-regress..., Schizophr. Res. (2016), http://dx.doi.oret al., 2014; Ostermann et al., 2012; Scheewe et al., 2013; Snethen et
al., 2014; Vancampfort et al., 2013a, 2013c, 2015a; Vreeland et al.,
2003; Wang et al., 2012) Full details of the search results are summa-
rized in Fig. 1.3.2. Details of included studies and participants' characteristics
Full details of the included studies and participants are presented
in Table 1. Brieﬂy, there were 3453 individuals with schizophrenia
with a mean age of 40.0 years (range 17–60.3 years), 64.0% male
(range 0–100%) and mean illness duration of 14.4 years (range 1.9–
26.2 years). The mean BMI of participants was 30.1 (range 23.5–
38.7) with the mean proportion of 94% (19.5–100%) taking antipsy-
chotic medication (details, where available, in Table 1). Two studies
recruited people with FEP (Curtis et al., 2015; Firth et al., 2016), the
majority included people with schizophrenia spectrum (full details
in Table 1). Overall, 12 studies assessed physical activity using an ob-
jective measure (Beebe et al., 2011; Gomes et al., 2014, 2015;
Gorczynski et al., 2014; Kimhy et al., 2014; Leutwyler et al., 2013,
2015; McCreadie, 2003; Scheewe et al., 2013; Snethen et al., 2014;
Wang et al., 2012), one utilized an objective and subjective measure
(Lindamer et al., 2008), while the remaining studies used a SRQ, pri-
marily the IPAQ SF (Table 1). Light, moderate, moderate-vigorous
and vigorous physical activity was captured by 22 (n = 2658), 22
(n = 2563), 16 (n = 559) and 21 (n = 2533) study estimates
respectively.w diagram.
oplewith schizophrenia engage in? A systematic review, comparative
g/10.1016/j.schres.2016.05.017
Table 1
Details of included studies, participants and physical activity measurement.
Author Study setting
and location
Physical
activity
measurement
Details of PA and
reference period
Schizophrenia participants (N = only participants with valid
physical activity data)
Control group
Arbour-Nicitopoulos
(2010)
Outpatient,
Canada, Cross
sectional study
SRQ IPAQ-SF, last 7 day
recall
N = 92 schizophrenia spectrum, mean age 37.5 years, 65.2%
male, 13.5 illness duration, BMI 29.1. 100% taking
antipsychotics.
No healthy control group
Arbour-Nicitopoulos
(2014)
Outpatient,
Canada, pre and
post study
SRQ IPAQ-SF, last 7 day
recall
N = 26 schizophrenia spectrum, mean age 41.5 years, 61.5%
males and mean BMI 32.4. BPRS 33.4.
No healthy control group
Attux et al. (2013) Outpatient,
Brazil, pre and
poststudy
SRQ IPAQ-SF, last 7 day
recall
Control group: N = 66 psychosis, 38.3 years, 61% male, 13.1
years illness duration and BMI 29.9, 99% taking antipsychotics.
PANNS total 61.6, negative 12.1 & positive 18.7. 2.8 Calgary
depression scale.
Intervention group: N = 60 psychosis, 36.2 years, 62% male, 14.3
years illness duration, BMI 29.1. PANSS total 56.4, negative 12.3,
positive 16.2. Calgary depression scale 2.6
No healthy control group
Baker et al. (2014) Outpatient,
Australia, pre
and post study
SRQ IPAQ-SF, last 7 day
recall
N = 17 psychosis, 33.9 years, 53% male, 12.4 years illness
duration. 100% taking antipsychotics.
No healthy control group
Beebe et al. (2011) Outpatient, US,
RCT
OBJ Pedometer, minutes
walked over past
month
N = 49 schizophrenia, 57% male 80% taking antipsychotics. No healthy control group
Bredin et al. (2013) Community,
Canada, pre and
poststudy
SRQ Godin Shephard
Leisure Time
Questionnaire average
weekly PA
N = 13 schizophrenia, 30.9 years, 53.8% male, BMI 29, 100%
taking antipsychotics. PANSS total 99.2.
No healthy control group
Brunero and Lamont
(2010)
Inpatient,
Netherlands,
cross sectional
SRQ Questions if completed
more or b150 min PA
in last week
N = 99 schizophrenia, 38.5 years, 62% male, BMI 30.75, 100%
taking antipsychotics
No healthy control group
Curtis et al. (2015) Outpatient, Aus,
prospective
study
SRQ IPAQ-SF, last 7 day
recall
N = 15 FEP, 20 years, 44% male BMI 23.5, 100% taking
antipsychotics.
No healthy control group
Faulkner et al.
(2006)
Outpatient,
Canada, pre and
poststudy
SRQ IPAQ-SF, last 7 day
recall
N = 35 schizophrenia, 39.66 years, 63% male, BMI 30.56, 100%
taking antipsychotics.
No healthy control group
Firth et al. (2016) Community, UK,
pre and
post-test study
SRQ IPAQ-SF, last 7 day
recall
N = 29 FEP, 25.8 years, 81% male, 1.9 illness duration, BMI 30.2,
100% taking antipsychotics. PANSS total 78.6, negative18.8,
positive 19.2 and 22.3 BDI.
No healthy control group
Gardner-Sood et al.
(2015)
Community, UK,
RCT
SRQ IPAQ-SF, last 7 day
recall
N = 299 schizophrenia, 43.4 years, 69.0% males, 15.7 years
illness duration, PANSS total 51.2, positive 11.8, negative 12.9
No healthy control group
Gomes et al. (2014) Community,
Portugal, quasi
experimental
OBJ GTX3, 7 consecutive
days
Control N= 11 schizophrenia, 40 years, 84% male, BMI 27.5,
100% taking antipsychotics.
Intervention N= 8 schizophrenia, 39 years, 84% male, BMI 29,
100% taking antipsychotics.
No healthy control group
Gomes et al. (2015) Community,
Portugal, cross
sectional
OBJ GTX3, 7 consecutive
days
N = 32 schizophrenia, 41.16 years, 71.9% male, BMI 29.6 N = 32, 38.56 years,
68.8% male, BMI 27.66
Gorczynski et al.
(2014)
Community,
Canada, cross
sectional
OBJ Uni-axial
accelerometer
(ActiGraph), 7
consecutive days
N = 4 schizophrenia, 29.5 years, 50% male, 11.8 years illness
duration, BMI 38.7, 100% taking antipsychotics.
No healthy control group
Janney et al. (2015) Community, US,
cross sectional
SRQ Modiﬁed Activity
Questionnaire, last 7
days
N = 252 schizophrenia, 35.7% male, 80% taking antipsychotics No healthy control group
Janney et al. (2015) Outpatient, US,
cross sectional
OBJ ActiGraph, 7
consecutive days
N = 46 schizophrenia, 45.6 years, 58% male, 15.5 years illness
duration, BMI 38, 100% taking antipsychotics. 58.8 PANSS total
No healthy control group
Keller-Varady et al.
(2015)
Germany, pre
and poststudy
SRQ Questions if completed
more or b150 min PA
in last week
Intervention N= 22 schizophrenia, 37.3 years, 73% male, 10.2
years illness duration, BMI 29.4, 100% taking antipsychotics.
Control N= 19 schizophrenia, 35.8 years, 71% male, 11.7 years
illness duration, BMI 27.4, 80% taking antipsychotics.
N = 32, 38.56 years,
68.8% male, BMI 27.66
Kimhy et al. (2014) Outpatient, US,
cross sectional
OBJ ActiGraph for 36 h N = 32 schizophrenia, 37.3 years, 63% male, BMI 32.1, 100%
taking antipsychotics. 7.59 BDI
No healthy control group
Leutwyler et al.
(2015)
Community and
inpatients, US,
cross sectional
OBJ Sensewear armband, 5
consecutive days
N = 30 schizophrenia, 60 years, 60% male, BMI 30.3, 90% taking
antipsychotic medication. PANSS total 75, positive 16 and
negative scale 13.5
No healthy control group
Leutwyler et al.
(2015)
Community and
inpatients, US,
cross sectional
OBJ SenseWear Pro
armband, 7
consecutive days
N = 15 schizophrenia, 60.3 years, 80% male. No healthy control group
Lindamer et al.
(2008)
Community, US,
cross sectional
OBJ and SRQ ActiGraph, 3 of last 7
days.
Yale Physical Activity
Scale, typical week in
last month.
N = 16 objective data and N = 54 SRQ data. 50.7 years, 59.3%
male, BMI 30.5
N= 27 SRQ data and N=
6 OBJ data. 52.2 years,
59.3% male, BMI 27.8
Lovell et al. (2014) Community, UK,
RCT
SRQ IPAQ-SF, last 7 day
recall
N = 102 schizophrenia, 25.7 years, BMI 32.4, 100% taking
antipsychotic.
No healthy control group
Masa-Font et al. Outpatient, SRQ IPAQ-SF, last 7 day N = 223 schizophrenia, 45 years, 61.4% male, BMI 32.2, 100% No healthy control group
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Table 1 (continued)
Author Study setting
and location
Physical
activity
measurement
Details of PA and
reference period
Schizophrenia participants (N = only participants with valid
physical activity data)
Control group
(2015) Spain, RCT recall taking antipsychotics.
McCreadie (2003) Community, UK,
cross sectional
SRQ Scottish Physical
Activity Questionnaire,
last 7 days.
N = 72 males, 43 years 100% males, illness duration 21 years.
N = 29 females, 50 years, illness duration 21 years
No healthy control group
McKibbin et al.
(2006)
Community, US,
cross sectional
OBJ Accelerometer, 3
consecutive days
Control N= 29 schizophrenia, 54.8 years, 62.1%, illness duration
25.5 years, BMI 32.9, 100% taking antipsychotics.
Intervention N= 28, 53.1 years, 67.9% male, illness duration
26.2 years, BMI 33.6
No healthy control group
McLeod et al. (2009) Outpatient, Aus,
cross sectional
SRQ Active Australia
survey, last 7 days.
N = 125 schizophrenia, 40.3 years, 64.8%, BMI 28.92 No healthy control group
Morgan et al. (2014) Community,
Aus, prospective
SRQ IPAQ-SF, last 7 day
recall
N 1134 schizophrenia, 39 years, 66% male, illness duration 15.25
years, 91% taking antipsychotic medication.
No healthy control group
Ostermann et al.
(2012)
Inpatient,
Germany, cross
sectional
SRQ IPAQ-SF, last 7 day
recall
N = 23 schizophrenia, 28.4 years, 69.6% males, illness duration
4.1 years, BMI 24. 82.6% taking antipsychotics, PANSS 74 total
symptoms.
N = 23, 28.2 years, 73.9%
male, BMI 23.6
Scheewe et al.
(2013)
Netherlands,
cross sectional
OBJ Sensewear armband, 4
consecutive days
N = 62 schizophrenia, 29.6 years, 73% male, illness duration 6.6
years, BMI 26.3. 100% taking antipsychotics. PANSS total 62.6,
positive 15.52and negative scale 17.46
N = 52, 29.3 years, 65.5%
male, BMI 23.9.
Snethen et al.
(2014)
Outpatient, US,
cross sectional
OBJ Uni-axial
accelerometer
(ActiGraph), 8
consecutive days
N = 30 schizophrenia, 50.6 years, 89.3% male, BMI 32.18 No healthy control group
Vancampfort et al.
(2013b)
In and
outpatients,
Belgium, cross
sectional
SRQ IPAQ-SF, last 7 day
recall
N = 138 schizophrenia, 41.2 years, 67% male, BMI 27.7 No healthy control group
Vancampfort et al.
(2013c)
In and
outpatients,
Belgium, cross
sectional
SRQ IPAQ-SF, last 7 day
recall
N = 80 schizophrenia, 36.8 years, 68.8% male, illness duration
12.8 years, BMI 26.3. 99% taking antipsychotics.
N = 40, 37.1 years, 68%
male, BMI 25.7
Vancampfort et al.
(2015b)
In and
outpatients,
Belgium, cross
sectional
SRQ IPAQ-SF, last 7 day
recall
N = 50 schizophrenia, 33.8 years, 68% male, 12.4 illness
duration, BMI 25.7.
No healthy control group
Vreeland 2003
Intervention
Community, US,
CCT
SRQ Minutes exercise per
week.
N = 31 schizophrenia, 42.6 years, 61% male, BMI 34.3, 100%
taking antipsychotics.
No healthy control group
Wang et al. (2012) US, cross
sectional
OBJ Uniaxial accelerometer
(Actigraph), 4
consecutive days
N = 48 schizophrenia, 72 years, 21.5% male, 100% taking
antipsychotics.
No healthy control group
Key: SRQ = self-report questionnaire, OBM = objective measurement, PA = physical activity, BMI = body mass index, IPAQ-SF = International Physical Activity Questionnaire Short
Form, US = United States, Aus = Australia, UK = United Kingdom, PANSS = positive and negative symptoms scale, FEP = ﬁrst episode psychosis, BDI Beck Depression Inventory.
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Full details of all meta-analysis results, including heterogeneity and
publication bias data are presented in Table 2. Key results are highlight-
ed below.
4.1. Meta-analysis of daily amount of light physical activity
Across all 22 studies, people with schizophrenia engaged in
80.44 min (95% CI 68.3–92.5, n = 2658) light physical activity per
day. The trim and ﬁll analysis demonstrated a slightly increased mean
amount of light physical activity (88.91 min, Table 2).
4.2. Subgroup analyses
4.2.1. Differences in light physical activity in self-report and objective
measurement
Signiﬁcantly (p b 0.001) higher levels of light physical activity were
reported with objective measures versus SRQ. The difference between
objective (192.1 min per day, 95% CI 136.2–247.9, n = 235) and SRQ
(24.8 min per day, 95% CI 16.5–33.2, n = 2333) was larger after the
trim and ﬁll analysis.
4.2.2. Primary psychiatric diagnosis
Full details are presented in Table 2. Brieﬂy, data from 17 studies
(n = 2294) illustrated that people with schizophrenia engaged inPlease cite this article as: Stubbs, B., et al., Howmuch physical activity do pe
meta-analysis and meta-regress..., Schizophr. Res. (2016), http://dx.doi.orhigher levels of light physical activity (98.58 min per day, 95% CI
83.59–113.56) than did other diagnostic groups.
4.2.3. Study setting
Higher levels of light physical activity were observed in community
(n = 1223, 83.33 min per day, 95% CI 47.6–119.1) and outpatient set-
tings (studies = 14, n = 1060, 99.3 min per day, 95% CI 80.1–118.5)
than in inpatient settings.
4.2.4. Meta-regression of light physical activity
Meta-regression analysis (Table 3) illustrated that increasing age
(β= 8.4, p = 0.0009, R2 = 0.35), a higher percentage of males (β=
5.02, p= 0.0022, R2 = 0.31) and objective measures moderated higher
light PA.
4.3. Meta-analysis of daily amount of moderate physical activity
Across 22 studies, after the Duval and Tweedie trim and ﬁll adjust-
ment the pooled mean of moderate physical activity per day was
16.2 min (95% CI 11.4–21.1, n = 2563).
4.3.1. Differences in moderate physical activity in self-report and objective
measurement
Signiﬁcantly higher levels of moderate physical activity (42.2 min
per day, 95% CI 34.3–50.1, n = 142) were reported in objective mea-
sures versus self-report.oplewith schizophrenia engage in? A systematic review, comparative
g/10.1016/j.schres.2016.05.017
Table 2
Meta-analysis results of sedentary behaviour among people with psychosis.
Analysis Number of study
estimates
Number of
participants
Meta-analysis Between group p
value
Trim and ﬁll effect size (95% CI) [adjusted
studies]
I2
Main analysis Min per
day
95% CI
Light physical activity
Mean light PA per day 22 2568 80.44 68.32 92.52 88.91 (69.0–108.7) [1] 99
PA measurement b0.001
Objective PA 7 235 188.16 173.44 202.88 192.1 (136.2–247.9) [1] 97
SRQ 15 2333 33.30 25.17 41.43 24.8 (16.5–33.2) [5] 90
Primary diagnosis b0.001
First episode
psychosis
2 131 42.2 21.1 445.7 N/A 76
Schizophrenia
spectrum
17 2294 98.58 83.59 113.56 78.8 (63.8–93.8) [2] 98
Mixed psychosis 3 143 33.73 0.254 67.72 Unchanged 0
Study setting 0.02
Community 4 1223 83.33 47.61 119.05 107.3 (11.9–202.7) [1] 98
Inpatient 1 66 49.5 0.279 126.99 N/A 0
Outpatient 14 1060 99.26 80.06 118.46 Unchanged 98
Mixed 3 219 23.97 −16.018 63.96 Unchanged 84
Moderate physical activity
Mean moderate PA
per day
22 2563 25.80 21.03 30.65 16.2 (11.4–21.1) [7] 94
PA measurement b0.001
Objective PA 7 142 42.22 34.34 50.11 35.6 (26.8–43.8) [3] 56
SRQ 15 2421 18.13 14.94 23.31 Unchanged 93
Primary diagnosis =0.04
First episode
psychosis
2 131 9.56 0.503 24.16 Unchanged 81
Schizophrenia
spectrum
17 2306 26.02 20.70 31.34 16.8 (11.2–22.3) [5] 95
Mixed psychosis 2 126 35.97 17.31 54.63 N/A 0
Study setting b0.001
Community 4 1281 13.69 3.42 23.96 6.42 (0.09–12.9) [2] 88
Inpatient 1 23 12.96 0.761 33.41 N/A 0
Outpatient 12 884 28.47 21.90 35.04 25.0 (16.5–33.4) [1] 97
Mixed 5 375 21.48 11.70 31.26 Unchanged 90
Vigorous physical activity
Mean vigorous PA per
day
21 2533 2.56 2.01 3.11 1.05 (0.48–1.62) [10] 94
PA measurement b0.001
Objective PA 6 112 0.412 0.025 0.849 0.17 (0.005–0.41) [3] 80
SRQ 15 2421 4.683 4.016 5.349 4.51 (2.80–6.22) [4] 82
Primary diagnosis b0.001
First episode
psychosis
2 131 3.796 1.723 5.868 Unchanged 92
Schizophrenia
spectrum
17 2276 2.199 1.657 2.741 0.91 (0.37–1.46) [7] 94
Mixed psychosis 2 126 11.568 6.315 16.821 N/A 0
Study setting =0.002
Community 4 1281 5.12 3.512 6.742 Unchanged 89
Inpatient 1 23 9.4 4.04 14.75 N/A 0
Outpatient 10 853 2.04 1.150 2.93 1.15 (0.33–1.98) [4] 88
Mixed 5 314 2.15 1.00 3.30 Unchanged 93
Unclear 1 62 10.5 5.01 15.98 N/A 0
Moderate-vigorous physical activity
Mean vigorous PA per
day
16 559 36.53 27.55 45.52 47.1 (31.5–62.8) [4] 96
PA measurement 0.74
Objective PA 9 284 37.79 25.90 49.68 Unchanged 90
SRQ 7 275 34.84 21.45 48.24 49.8 (20.2–78.7)) [2] 97
Primary diagnosis 0.008
First episode
psychosis
2 44 6.42 0.175 30.39 N/A 0
Schizophrenia
spectrum
14 515 41.16 31.68 50.65 50.3 (32.9–67.0) [3] 96
Study setting 0.008
Community 4 99 17.57 0.273 37.87 14.8 (5.91–23.8) [1] 89
Outpatient 8 200 39.37 24.52 54.22 Unchanged 94
Mixed 2 130 27.85 0.80 56.50 N/A 98
Unclear 2 130 78.88 49.29 108.49 N/A 99
Bold = statistically signiﬁcant result.
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Table 3
Meta regression of moderators of physical activity in schizophrenia.
Moderator Number of study estimates β 95% CI p value R2
Light physical activity
Mean age 20 8.3654 3.4203 13.3104 0.0009 0.35
% males 21 5.0179 1.8032 8.2327 0.0022 0.31
Illness duration 10 2.0452 −3.345 7.4354 0.4571 0.06
BMI 17 9.1653 −5.2454 23.5761 0.2126 0.09
% taking antipsychotic medication 16 0.9972 −0.6467 2.6411 0.2345 0.08
Total psychiatric symptoms 6 −0.1754 −1.6393 1.2885 0.8144 0.01
Positive symptoms 6 13.4148 −2.4846 29.3142 0.0982 0.32
Negative symptoms 6 10.207 −7.5563 27.9703 0.2601 0.10
Depressive symptoms 6 −0.6065 −1.9334 0.7204 0.3703 0.18
Self-report v objective measure (SRQ as reference) 22 171.0681 134.1401 207.9962 b0.001 0.80
Moderate physical activity
Mean age 21 0.8021 −0.2345 1.8387 0.1294 0.11
% males 21 0.7922 −0.1594 1.7438 0.1027 0.14
Illness duration 8 −0.7569 −4.8082 3.2943 0.7142 0.01
BMI 18 −0.392 −5.2285 4.4445 0.8738 0
% taking antipsychotic medication 16 0.3385 −0.2827 0.9597 0.2855 0.07
Total psychiatric symptoms 7 0.2859 −0.7253 1.2971 0.5795 0.04
Positive symptoms 8 2.8037 −2.7203 8.3277 0.3199 0.11
Negative symptoms 8 2.4568 −3.3291 8.2426 0.4053 0.09
Depressive symptoms 7 −1.4013 −3.0586 0.2559 0.0975 0.41
Self-report v objective measure (SRQ as reference) 22 23.3737 5.3933 41.3541 0.0108 0.24
Vigorous physical activity
Mean age 20 −0.1738 −0.3259 −0.0216 0.0252 0.21
% males 19 −0.0805 −0.2192 0.0582 0.2555 0.08
Illness duration 9 0.0646 −0.3994 0.5285 0.7849 0.02
BMI 17 −0.147 −0.9264 0.6324 0.7117 0.01
% taking antipsychotic medication 15 −0.0446 −0.0379 0.1271 0.2894 0.09
Total psychiatric symptoms 7 0.0067 −0.1206 0.134 0.9177 0
Positive symptoms 7 −0.201 −0.9395 0.5374 0.5936 0
Negative symptoms 7 0.408 −0.3667 1.1828 0.302 0.09
Depressive symptoms 7 −0.4911 −0.9056 −0.0766 0.0202 0.48
Self-report v objective measure (SRQ as reference) 22 4.8836 2.1192 7.6481 0.0005 0.48
Moderate-vigorous physical activity
Mean age 16 −0.0993 −1.6806 1.482 0.902 0
% males 16 0.7171 −0.5331 1.9673 0.2609 0.08
Illness duration 8 −1.2662 −4.4097 1.8773 0.4298 0.07
BMI 15 −0.9334 −5.3371 3.4703 0.6778 0.01
% taking antipsychotic medication 13 4.906 −5.5606 15.3725 0.3583 0.06
Total psychiatric symptoms 5 −0.475 −3.1042 2.1542 0.7233 0.03
Positive symptoms 5 1.1502 −7.9344 10.2348 0.804 0.01
Negative symptoms 5 2.658 −6.869 12.1849 0.5845 0.06
Depressive symptoms 4 −3.4294 −7.2614 0.4027 0.0794 0.45
Self-report v objective measure (SRQ as reference) 16 1.9545 −28.5001 32.4092 0.8999 0
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Signiﬁcantly higher levels ofmoderate physical activity were seen in
schizophrenia spectrum (Table 2) compared to FEP and those with
mixed psychotic disorder.4.3.3. Study setting
Signiﬁcantly higher moderate physical activity levels were observed
in outpatient (n = 884, 28.5 min per day, 95% CI 21.9–35.04) versus
other settings.4.3.4. Meta-regression of moderate physical activity
Only objective measurements moderated higher levels of moderate
physical activity (β= 23.4, p = 0.01, R2 = 0.24).4.4. Meta-analysis of daily amount of vigorous physical activity
After adjustment for Duval and Tweedie's trim and ﬁll, the meta-
analysis demonstrated people with schizophrenia spend 1.05 min per
day engaging in vigorous PA (95% CI 0.5–1.6, n = 2553).Please cite this article as: Stubbs, B., et al., Howmuch physical activity do pe
meta-analysis and meta-regress..., Schizophr. Res. (2016), http://dx.doi.or4.4.1. Differences in self-report and objective measures of vigorous physical
activity
Signiﬁcantly (p b 0.001) higher levels of vigorous PA were reported
in SRQ measures (4.51 min, 95% CI 2.8–6.2, n = 2421) versus objective
measures (0.2, 95% CI 0.005–0.41, n = 112).4.4.2. Primary psychiatric diagnosis
Higher levels of vigorous PA were observed in those with psychosis
versus schizophrenia spectrum only (Table 2).4.4.3. Study setting
Higher levels of vigorous PA were reported in one inpatient study
versus other settings (Table 2).4.4.4. Meta-regression of vigorous physical activity
Older people (β= −0.17, p = 0.03, R2 = 0.21) and participants
with higher depressive symptoms (β= −0.49, 0.02, R2 = 0.48) en-
gaged in less vigorous PA. SRQ also moderated a high level of vigorous
PA (Table 3).oplewith schizophrenia engage in? A systematic review, comparative
g/10.1016/j.schres.2016.05.017
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The mean adjusted amount of moderate-vigorous PA was 47.1 min
per day (95% CI 31.5–62.8, n = 559).
4.5.1. Difference in self-report and objective measurement of physical
activity
No difference was observed (Table 2).
4.5.2. Primary psychiatric diagnosis
People with schizophrenia engaged in more moderate-vigorous PA
(41.2, 95% CI 31.7–50.7, n = 515) than FEP participants (6.4, 95% CI
0.2–30.4, n = 44) although restricted to two studies using SRQ.
4.5.3. Study setting
Higher levels ofmoderate-vigorous PAwere seen in outpatient com-
pared to inpatient settings.
4.5.4. Meta-regression of moderate-vigorous physical activity
No signiﬁcant moderators were identiﬁed (see Table 3).
4.6. What proportion of people with schizophrenia meet recommended
physical activity targets?
Across 12 studies and 646 people with schizophrenia, 56.6% (95% CI
45.8–66.8, I2=81%)met the recommended 150min ofmoderate phys-
ical activity per week. The proportion of people meeting the targets
were similar when assessed via objective measures (54.2%, 95% CI
24.5–79.8, studies = 2) or SRQ (56.9%, 95% CI 45.1–68.0, studies 10).
People in the community (35.2%, 95% CI 18.8–56.1, studies = 3) and
outpatient settings (41.5%, 95% CI 29.2–54.9%, studies = 3) were less
likely to meet PA guidelines compared to mixed (69.5%, 95% CI 58.0–
79.0, studies = 3), inpatient (51.5%, 95% CI 31.7–70.7, studies = 1)
and unclear settings (81.2%, 95% CI 63.1–91.6, studies = 3).
4.7. Differences in physical activity in people with schizophrenia and
controls
The comparative meta-analysis results are summarized in Table 4.
No signiﬁcant difference was observed in light PA between people
with schizophrenia (n = 150) and controls (n = 101). People with
schizophrenia (n = 213) engaged in signiﬁcantly less moderate PA
(hedges g =−0.45, 95% CI−0.79 to−0.1, p = 0.01) versus controls
(n = 156) equating to a mean difference of−14.2 min (95% CI−28.0
to-0.16). People with schizophrenia also engaged in signiﬁcantly less
vigorous PA (g =−0.39, 95% CI−0.60 to−0.18) equating to a mean
difference of−3.42 min (95% CI−6.15 to−0.59).Table 4
Meta-analysis investigating physical activity levels in schizophrenia participants versus contro
Analysis Number of
studies
Number of participants Meta-analysis
Schizophrenia Control Hedges
g
95%
Light Physical activity 4 150 101 −0.262 −0
Objective 2 48 38 −0.504 −1
SRQ 2 103 63 −0.131 −0
Moderate physical activity 5 213 156 −0.446 −0
Objective 3 110 93 −0.326 −0
SRQ 2 113 63 −0.577 −1
Vigorous physical activity 5 213 156 −0.390 −0
Objective 3 110 93 −0.315 −0
SRQ 2 113 63 −0.490 −0
Moderate to vigorous physical
activity
2 94 87 −0.480 −0
Bold = statistically signiﬁcant result.
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The current study is, to our knowledge, the ﬁrst to determine PA
levels and predictors in people with schizophrenia. We found that
people with schizophrenia spend almost 90 min participating in
light intensity PA and N45 min in moderate to vigorous PA per day.
More than half of the people with schizophrenia included in the
present meta-analysis met the recommended 150 min of at least
moderate PA per week. Nonetheless, although these data are prom-
ising, our meta-analysis also shows that people with schizophrenia
still engage in signiﬁcantly less moderate and vigorous PA than
healthy controls.
The observation that there was no difference in level of light PA be-
tween people with schizophrenia and controls might be due to the fact
that walking is the primary mode of transportation for most people
with schizophrenia (Vancampfort et al., 2013b). Higher levels of light
PA in community and outpatient settings seem to conﬁrm this hypoth-
esis. Of interest, our meta-regression analysis illustrated that objective
measuresmoderated higher light PA indicating that peoplewith schizo-
phrenia underestimate the time they engage in light PA. Older people
with schizophrenia seem to engage in higher levels of light PA than
their younger counterparts, suggesting that light PA is preferable to
thosewith established illness. Recent research established that walking
is a preferred method of physical activity among people with psychotic
disorders (Fraser et al., 2015; Soundy et al., 2014c). Rehabilitation pro-
grams should therefore focus in particular on this type of PA, especially
in older patients. Research in the general population has demonstrated
that walking can reduce diastolic and systolic blood pressure, weight
and overall cardiovascular risk (Hanson and Jones, 2015). A previous re-
view (Soundy et al., 2013) found that a paucity of RCTs had investigated
walking interventions in people with schizophrenia, but there is evi-
dence to suggest thatwalking can improve health outcomes in this pop-
ulation. Given our ﬁndings, our data suggests that walking might be an
appropriate intervention to encourage older people with schizophrenia
and established illness to ascertain the beneﬁts of an active lifestyle. Fu-
ture RCTs are required to test this hypothesis.
However, for optimal health beneﬁts people with schizophrenia
should however also strive to engage in moderate to vigorous PA
(Vancampfort, 2012). In relation to vigorous PA, it appears that people
with schizophrenia engage in on average only 2.4 min per day which
is concerning. We did ﬁnd some interesting differences between levels
of moderate and vigorous PA according to the setting and assessment
method. While signiﬁcantly higher levels of moderate PA were ob-
served in outpatients and with objective assessment methods, the op-
posite was true for vigorous PA, i.e. lower levels were observed in
outpatients and with objective assessment methods. These data indi-
cate that people with schizophrenia seem to underestimate their levels
of moderate and overestimate their levels of vigorous PA (Rosenbaum
and Ward, 2016).ls.
Publication bias Heterogeneity
CI p value Trim and ﬁll effect size (95% CI)
[adjusted studies]
I2
.682 0.1573 0.22 Unchanged 55
.30 0.294 0.29 N/A 82
.837 0.575 0.57 N/A 0
.792 −0.099 0.01 −0.63 (−0.97—0.28) [2] 57
.840 0.187 0.21 Unchanged 55
.172 −0.089 =0.04 N/A 74
.602 −0.179 b0.001 −0.44 (−0.64—0.25) [2] 0
.596 −0.04 0.02 Unchanged 1
.812 −0.168 0.003 N/A 20
.965 −0.0045 0.04 N/A 59
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people with schizophrenia, who are signiﬁcantly less physically active
and physically ﬁt than the general population (Vancampfort et al.,
2015b, 2016b), havedifﬁculties in accurately recalling the intensity of var-
ious physical activities and therefore perceivemoderate intensity physical
activities as vigorous. For example, the IPAQ deﬁnes vigorous intensity PA
broadly as an activity causing signiﬁcantly harder breathing (Craig et al.,
2003). In physically inactive and unﬁt patients moderate intensity PA
might cause people to start already breathing signiﬁcantly harder. Clinical
variability inmoodmay also inﬂuence the ability to accurately respond to
self-report questionnaires, especially among people who experience
symptom ﬂuctuations (Soundy et al., 2014b). However, in our meta-re-
gression we were unable to identify any potential moderators of moder-
ate and moderate-vigorous PA. Clearly, this calls for the development of
accurate and clinically useful measures for clinical practice.
The higher levels of vigorous PA in inpatients are of interest and
might be due to the increasing interest for sports as a valuable treat-
ment modality (Soundy et al., 2015), especially when delivered by spe-
cialized health care professionals (Vancampfort et al., 2016a). In
addition, inpatients are as such more likely to beneﬁt from such exper-
tise and structured planned PA interventions. Our data also indicate that
in particular depressive symptomsmight be a barrier for engaging in PA.
A reason for the association between symptoms of depression and less
time spent in vigorous PA might be the fact that feelings of depression
are associated with a lower self-efﬁcacy and increased negative out-
come expectations when having the intention to engage in sport activ-
ities (Kramer et al., 2014). In addition, lowermotivation and volition are
also key factors (Vancampfort et al., 2014).
Interestingly, we found that over 50% of people with schizophrenia
meet the recommended PA guidelines. The results remained robust
when we restricted the analysis to objective measures only, although
only two studies were included. Of interest, it does appear that there
are some slight variations in people with schizophrenia meeting PA
guidelines (with lower proportions in community and outpatient set-
tings). However, some caution should be attached to these analyses
due to the relatively limited number of studies. Nonetheless, our data
demonstrate that people with schizophrenia engage in signiﬁcantly
less moderate and vigorous PA versus controls.
While the results of this meta-analysis are novel, several limitations
should be noted. First, almost half of the included studies relied on data
drawn from SRQ. Second, we encountered heterogeneity in several of
the meta-analyses we undertook, which is expected when pooling ob-
servational data (Stroup et al., 2000). However, our meta-regression
analyses explained approximately half of the between study heteroge-
neity that we encountered. Third, there was a paucity of data on PA be-
havior among people at earlier stages of their illness (e.g. ﬁrst episode of
illness). Finally, there was inadequate information on antipsychotic
medication, thus precluding meta-analytical or meta-regression analy-
sis. Future research is required to understand the impact of speciﬁc an-
tipsychotics on PA behavior. Nevertheless, allowing for these caveats,
the current meta-analysis provides important information for clinicians
and researchers.
In conclusion, our data found that peoplewith schizophrenia engage
in signiﬁcantly less moderate and vigorous PA versus controls. People
with schizophrenia do not appear to engage in less light PA and future
interventions targeting light PA such as walking might offer a unique
opportunity to help older people with established illness to experience
the health beneﬁts of PA.
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